图书馆订阅: Guest
Begell Digital Portal Begell 数字图书馆 电子图书 期刊 参考文献及会议录 研究收集
肿瘤形成评论综述™
SJR: 0.631 SNIP: 0.503 CiteScore™: 2.2

ISSN 打印: 0893-9675
ISSN 在线: 2162-6448

肿瘤形成评论综述™

DOI: 10.1615/CritRevOncog.2014011455
pages 281-315

Development of Nanoscale Approaches for Ovarian Cancer Therapeutics and Diagnostics

Sarah A. Engelberth
SUNY College of Nanoscale Science and Engineering, Albany NY 12203
Nadine Hempel
SUNY College of Nanoscale Science and Engineering, Albany NY 12203
Magnus Bergkvist
SUNY College of Nanoscale Science and Engineering, Albany NY 12203

ABSTRACT

Ovarian cancer is the deadliest of all gynecological cancers and the fifth leading cause of death due to cancer in women. This is largely due to late-stage diagnosis, poor prognosis related to advanced-stage disease, and the high recurrence rate associated with development of chemoresistance. Survival statistics have not improved significantly over the last three decades, highlighting the fact that improved therapeutic strategies and early detection require substantial improvements. Here, we review and highlight nanotechnology-based approaches that seek to address this need. The success of Doxil, a PEGylated liposomal nanoencapsulation of doxorubicin, which was approved by the FDA for use on recurrent ovarian cancer, has paved the way for the current wave of nanoparticle formulations in drug discovery and clinical trials. We discuss and summarize new nanoformulations that are currently moving into clinical trials and highlight novel nanotherapeutic strategies that have shown promising results in preclinical in vivo studies. Further, the potential for nanomaterials in diagnostic imaging techniques and the ability to leverage nanotechnology for early detection of ovarian cancer are also discussed.


Articles with similar content:

Oral Controlled-Release Formulation in Veterinary Medicine
Critical Reviews™ in Therapeutic Drug Carrier Systems, Vol.23, 2006, issue 3
Stefan Soback, Eran Lavy, Amir Steinman
Theranostic Nanostructures for Ovarian Cancer
Critical Reviews™ in Therapeutic Drug Carrier Systems, Vol.36, 2019, issue 4
Bankuru Navyatha, Seema Nara
Nanoformulations for Delivery of Biomolecules: Focus on Liposomal Variants for siRNA Delivery
Critical Reviews™ in Therapeutic Drug Carrier Systems, Vol.30, 2013, issue 6
Tapan K. Dash , V. Badireenath Konkimalla
Lessons Learned from Gemcitabine: Impact of Therapeutic Carrier Systems and Gemcitabine’s Drug Conjugates on Cancer Therapy
Critical Reviews™ in Therapeutic Drug Carrier Systems, Vol.34, 2017, issue 1
Sathish Dyawanapelly, Animesh Kumar, Manish K. Chourasia
Pancreatic Cancer: An Emphasis on Current Perspectives in Immunotherapy
Critical Reviews™ in Oncogenesis, Vol.24, 2019, issue 2
Krishna Patel, Maya Nair, Riyaz Basha, Sohail Siraj, Jamboor K. Vishwanatha, Chloe Smith